CTSO
CTSO clinical trials: Cytosorbents Corp
Every trial on ClinicalTrials.gov where Cytosorbents Corp is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 25
- Trials linked
- 12
- As lead sponsor
- 13
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
CTSO on the catalyst calendar · CTSO registry changes
- Primary completion Aug 7, 2023ActualNo phase registeredNCT04976530Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)CytoSorbents, Inc · Hemorrhage, SurgicalCompletedCTSOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 30, 2030Sponsor estimateNo phase registeredNCT05077124Safe and Timely Antithrombotic Removal (STAR) RegistryCytoSorbents, Inc · Hemorrhage, SurgicalActive, not recruitingCTSOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2032Sponsor estimateNo phase registeredNCT05146336CytOSorb TreatMent Of Critically Ill PatientS RegistryCytoSorbents, Inc · Septic ShockRecruitingCTSOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2027Sponsor estimateNo phase registeredNCT04963920A RCT to Assess the Performance of CytoSorb for Shock Reversal in Patients With Vasoplegic Septic ShockCytoSorbents Europe GmbH · Septic ShockSuspendedCTSOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 29, 2024ActualNo phase registeredNCT05093504Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)CytoSorbents, Inc · Hemorrhage, SurgicalTerminatedCTSOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 18, 2022ActualNo phase registeredNCT03384875CytoSorb® Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac SurgeryCytoSorbents, Inc · Elective Cardiac SurgeryTerminatedCTSOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 20, 2022ActualNo phase registeredNCT04391920Registry of CytoSorb Therapy in COVID-19 ICU PatientsCytoSorbents, Inc · COVID-19CompletedCTSOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2016Sponsor estimatePhase 2NCT02111018Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With RhabdomyolysisCytoSorbents, Inc · RhabdomyolysisWithdrawnCTSOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2023Sponsor estimateNo phase registeredNCT05131230CytoSorb® in Patients With Acute on Chronic Liver FailureCytoSorbents Europe GmbH · Acute on Chronic Liver FailureWithdrawnCTSOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 4, 2021ActualNo phase registeredNCT04131959Ticagrelor CytoSorb HemoadsorptionCytoSorbents, Inc · Emergent Cardiothoracic SurgeryTerminatedCTSOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 14, 2021ActualNo phase registeredNCT04625764Ticagrelor Removal Study Using CytoSorb® 300 mL Device During CPB in Patients Undergoing Emergent Cardiothoracic SurgeryCytoSorbents Europe GmbH · Acute Coronary SyndromeTerminatedCTSOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2016ActualNo phase registeredNCT02566525CytoSorb Reduction of Free Hemoglobin During Cardiac SurgeryCytoSorbents, Inc · Elective Cardiac SurgeryCompletedCTSOLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 30, 2027Sponsor estimateNo phase registeredNCT06079021COOLEY- Study: aCute On chrOnic Liver failurE Using the cYtosorb DeviceUniversity Hospital, Antwerp · Acute-On-Chronic Liver FailureRecruitingCTSOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 28, 2020ActualNo phase registeredNCT03266302Hemoadsorption for Prevention of Vasodilatory Shock in Cardiac Surgery Patients With Infective EndocarditisJena University Hospital · Infective EndocarditisCompletedCTSOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2024Sponsor estimateNo phase registeredNCT04596813Role of Cytosorb in Left Ventricular Assist Device ImplantationImperial College London · Heart FailureUnknown statusCTSOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 19, 2022ActualPhase 3NCT04643639Assessing the Effects of CytoSorb Hemoperfusion on the Development on ImmunoparalysisRadboud University Medical Center · SepsisCompletedCTSOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2023Sponsor estimateNo phase registeredNCT04013269Adjuvant Therapy With CytoSorb in Refractory Septic ShockUniversitätsklinikum Hamburg-Eppendorf · Septic ShockUnknown statusCTSOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 16, 2022ActualNo phase registeredNCT05259514CytoSorb SAH TrialEmanuela Keller · Aneurysmal Subarachnoid HaemorrhageTerminatedCTSOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2017ActualNo phase registeredNCT02606799Extracorporeal Elimination of Cytokines Following Abdominal-thoracic EsophagectomyUniversitätsklinikum Hamburg-Eppendorf · InflammationTerminatedCTSOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2020ActualNo phase registeredNCT03945708Does Whole Blood Adsorber During CPB Reduce Vasoactive Drugs Postoperatively in Endocarditis Patients Undergoing Valve Surgery?Emma Hansson · Infective EndocarditisCompletedCTSOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 24, 2018ActualNo phase registeredNCT04910893Cytokine Adsorption in Severe, Refractory Septic ShockUniversity of Zurich · Septic ShockCompletedCTSOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2023Sponsor estimateNo phase registeredNCT04048434Extracorporeal Cytokine Adsorption as Additive Treatment of CAR-T Associated Cytokine Release Syndrome (CRS)Hannover Medical School · Cytokine Release SyndromeUnknown statusCTSOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2019Sponsor estimateNo phase registeredNCT03104179Removal of Cytokines in Patients Undergoing Cardiac Surgery With CPBKlinikum Nürnberg · Extracorporeal CirculationUnknown statusCTSOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2018Sponsor estimatePhase 4NCT03082469Pancreatitis CytoSorbents (CytoSorb®) Inflammatory Cytokine RemovalTechnical University of Munich · Pancreatitis, AcuteUnknown statusCTSOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2015ActualPhase 3NCT01879176Cytokine Removal in Cardiopulmonary Bypass PatientsMedical University of Vienna · Elective Cardiac Surgical InterventionsCompletedCTSOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner